Immunosuppressive Agents: all 5,940 studies that test it
Page 5 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- CAR T-cell Therapy in Patients With Renal DysfunctionRecruitingNCT05909059Phase 2
- Venetoclax Combined With Azactidine in the Treatment of ALALRecruitingNCT05901974Phase 2
- Delayed Tolerance Through Mixed ChimerismRecruitingNCT05900401Phase 1/2
- Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin CancerRecruitingNCT05896839Phase 1/2
- Effect of Adalimumab Therapy on Psoriasis PatientNot yet recruitingNCT05889338Not applicable
- Efficacy of Ginger Muco-bioadhesive Gel in Management of Oral Lichen Planus With Immunohistochemical AnalysisNot yet recruitingNCT05882864Phase 4
- A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung DiseaseRecruitingNCT05878717Phase 2/3
- Feasibility Pilot Sequential Multiple Assignment Randomized Trial (SMART) for Acute Severe Ulcerative ColitisRecruitingNCT05867329Phase 4
- Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus NephritisRecruitingNCT05863936Phase 3
- A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast CancerRecruitingNCT05862064Phase 3
- Immune Thrombocytopenia Management in AdultsRecruitingNCT05861297Phase 4
- Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical TransplantRecruitingNCT05849207Phase 1
- TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia IIRecruitingNCT05848687Phase 1/2
- Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's SyndromeRecruitingNCT05845723Phase 2
- Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutantRecruitingNCT05843253Phase 2
- AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple SclerosisRecruitingNCT05832515Phase 1
- The Efficacy of Intra-articular Triamcinolone Acetonide 5mg vs. 10 mg vs. 40 mg in Patients With Knee OsteoarthritisRecruitingNCT05806021Phase 4
- Allo HSCT Using RIC and PTCy for Hematological DiseasesRecruitingNCT05805605Phase 2
- Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure DisordersRecruitingNCT05794425Phase 1/2
- Treatment Strategies for IgG4-RD Patients With Superficial Organ InvolvementRecruitingNCT05789030Not applicable
- Treatment Strategies for IgG4-RD Patients With Internal Organ InvolvementRecruitingNCT05789017Not applicable
- A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic AnemiaRecruitingNCT05757310Phase 1
- Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic TumorsRecruitingNCT05755854Phase 1
- HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesRecruitingNCT05751044Phase 1/2
- FUSCC Refractory TNBC Platform Study (FUTURE2.0)RecruitingNCT05749588Phase 2
- Study of Sirolimus in IgG4-related DiseaseNot yet recruitingNCT05746689Not applicable
- HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesRecruitingNCT05745714Phase 1/2
- A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)RecruitingNCT05736419Phase 2
- MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme MalignanciesRecruitingNCT05735717Phase 2
- Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal CancerRecruitingNCT05725200Phase 2
- Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid MalignanciesRecruitingNCT05705570Phase 1
- Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLLRecruitingNCT05702853Phase 1/2
- Selinexor in Combination With MTX+Ritu to Treat R/R CNSLRecruitingNCT05698147Phase 1/2
- Effect of Obesity on Cyclosporine Blood Trough Level in Nephrotic Syndrome PatientsRecruitingNCT05696977Phase 4
- Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid TumorsRecruitingNCT05693844Phase 1/2
- HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid TumorsRecruitingNCT05681650Phase 1/2
- Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)RecruitingNCT05681260Phase 3
- A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabRecruitingNCT05675410Phase 3
- HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological MalignanciesRecruitingNCT05658640Phase 1/2
- CAV Regimen for R/R Ph- B-ALLRecruitingNCT05657652Not applicable
- Conversion of Maintenance Prograf to Envarsus in Liver Transplant RecipientsEnrolling by invitationNCT05655273Phase 4
- EBV CAR-T Cells for Nasopharyngeal CarcinomaRecruitingNCT05654077Early Phase 1
- TIL Cells for the Treatment of the Advanced Solid Tumors PatientsNot yet recruitingNCT05649618Early Phase 1
- TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid TumorsNot yet recruitingNCT05648994Early Phase 1
- Uterus Transplantation to Treat InfertilityRecruitingNCT05646992Phase 2/3
- Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell LymphomaRecruitingNCT05633615Phase 2
- The Clinical Efficacy of Immunomodulators in RA PatientsRecruitingNCT05626348Phase 4
- Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System LymphomaRecruitingNCT05600660Phase 2
- SNF Platform Study of HR+/ HER2-advanced Breast CancerRecruitingNCT05594095Phase 2
- Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's DiseaseNot yet recruitingNCT05584228Not applicable
- Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSLRecruitingNCT05583071Phase 2
- Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal CancersNot yet recruitingNCT05582590Phase 1
- Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant TherapyRecruitingNCT05582499Phase 2
- Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal Angiofibroma (JNA)RecruitingNCT05549167Phase 3
- Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed MedulloblastomaRecruitingNCT05535166Phase 2
- Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological MalignanciesRecruitingNCT05528887Phase 1
- Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)RecruitingNCT05521984Phase 1
- B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021RecruitingNCT05518383Phase 4
- Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKDRecruitingNCT05510323Phase 3
- Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same DonorRecruitingNCT05508009Phase 1/2
- Immunoclassification of Psoriasis: a Strategy for Precision MedicineRecruitingNCT05503875Not applicable
- MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LNRecruitingNCT05495893Phase 4
- Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor PatientsRecruitingNCT05468359Phase 1/2
- ChiCGB vs BEAM in High-risk or R/R LymphomasRecruitingNCT05466318Phase 3
- Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune ThrombocytopeniaNot yet recruitingNCT05459649Phase 2
- Sirolimus in Cutaneous SarcoidosisNot yet recruitingNCT05458492Phase 2
- Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic MalignanciesRecruitingNCT05443425Phase 1
- The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell TransplantationRecruitingNCT05436418Phase 1/2
- Pilot Trial for Treatment of Recurrent GlioblastomaRecruitingNCT05432518Early Phase 1
- Efficacy of a Sequential Treatment Strategy in Rheumatoid ArthritisRecruitingNCT05428488Phase 3
- Thal-Fabs: Reduced Toxicity Conditioning for High Risk ThalassemiaRecruitingNCT05426252Phase 1/2
- A Study for the Adjuvant Treatment of Breast CancerRecruitingNCT05420467Phase 4
- A Study for the Neoadjuvant Treatment of Breast CancerRecruitingNCT05420454Phase 4
- Impacts of Mechanistic Target of Rapamycin (mTOR) Inhibition on Aged Human Muscle (Rapamune)RecruitingNCT05414292Not applicable
- A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess BlastsRecruitingNCT05365035Phase 2
- Azathioprine in MOGADRecruitingNCT05349006Phase 3
- Abatacept in Immune Checkpoint Inhibitor MyocarditisRecruitingNCT05335928Phase 3
- Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic MalignanciesRecruitingNCT05327023Phase 1/2
- Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform HemangioendotheliomaRecruitingNCT05324384Phase 2
- Treateament of Newly Diagnosed Acute Monocytic Leukemia in ChildrenRecruitingNCT05313958Phase 2/3
- Fingolimod for Type 2 Diabetes MellitusRecruitingNCT05307731Phase 4
- Stand UP to Rheumatoid Arthritis (SUPRA)RecruitingNCT05305066Not applicable
- Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative RhabdomyosarcomaRecruitingNCT05304585Phase 3
- Allogeneic Hematopoietic Stem Cell Transplantation for 4/M NeuroblastomaNot yet recruitingNCT05303727Phase 2
- Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic CancersRecruitingNCT05296564Phase 1/2
- Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and LymphomaRecruitingNCT05294055Phase 2
- Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)RecruitingNCT05289167Phase 1/2
- Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney TransplantationEnrolling by invitationNCT05285878Phase 2
- R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS RelapseRecruitingNCT05257018Phase 2
- Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP PancreatitisRecruitingNCT05252754Phase 3
- Parsaclisib in Combination With CHOP in Participants With Previously Untreated PTCLNot yet recruitingNCT05238064Phase 1/2
- The Role of Sirolimus in Preventing Functional Decline in Older AdultsRecruitingNCT05237687Phase 2
- mTOR as Mediator of Insulin Sensitivity StudyRecruitingNCT05233722Not applicable
- Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian CancerRecruitingNCT05225363Phase 1
- Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast CancerRecruitingNCT05159193Phase 3
- Dose Dense Re-challenge of High Dose Methotrexate With Glucarpidase for Relapsed Primary Central Nervous System LymphomaRecruitingNCT05135858Phase 1
- New Clinical End-points in Patients With Primary Sjögren's SyndromeRecruitingNCT05113004Phase 2
- Multi-model Image of Immunosuppressive Agents in TAORecruitingNCT05110040Not applicable
- Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain CancerRecruitingNCT05106296Phase 1
- Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention StudyRecruitingNCT05104983Phase 2